S5–03–04: Previous water–maze spatial training attenuates early, but not late, progressive memory loss in 3xTg–AD mice
03 medical and health sciences
0302 clinical medicine
3. Good health
DOI:
10.1016/j.jalz.2006.05.365
Publication Date:
2006-08-17T17:13:15Z
AUTHORS (2)
ABSTRACT
not available. S5-03-06 C. ELEGANS IN MODIFIER GENES Gerald Schellenberg, University of Washington, Seattle, WA, USA. Contact e-mail: Zachdad@u.washington.edu Abstract not available.not available. THURSDAY, JULY 20, 2006 SYMPOSIA S5-04 THERAPEUTICS S5-04-01 PHARMACOLOGICAL TREATMENTS OF PSYCHIATRIC SYMPTOMS IN ALZHEIMER’S DISEASE Pierre N. Tariot, University of Rochester, Rochester, NY, USA. Contact e-mail: pierre_tariot@urmc.rochester.edu Abstract not available.not available. S5-04-02 ARE CHOLINESTERASE INHIBITORS EFFECTIVE TREATMENT FOR AGITATED BEHAVIOUR IN ALZHEIMER’S DISEASE? FIRST RESULTS OF THE CALM-AD TRIAL Robert Howard, Institute of Psychiatry, London, United Kingdom. Contact e-mail: r.howard@iop.kcl.ac.uk Abstract not available. S93 Symposia S5-04: Therapeuticsnot available. S93 Symposia S5-04: Therapeutics
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....